Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
Sec Filings Insider Trading - Xenon Pharmaceuticals Inc. (XENE)
Select Time period:

Enter Stock Ticker Symbol or Cik: SEC Cik Lookup Cik Lookup...

Search By Company or Insider Name: Powered by Google button
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch ==>> What is insider trading>>
XENE Insider Trading Transactions for Xenon Pharmaceuticals Inc.
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
Date
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-11-15
Purchase
2017-11-16
4:56 pm
Xenon Pharmaceuticals Inc. XENE AZAB MOHAMMAD
Director
15,000 $2.219 $33,280 44,210
(Direct)
View
2017-09-21
Purchase
2017-09-25
5:00 pm
Xenon Pharmaceuticals Inc. XENE AZAB MOHAMMAD
Director
10,000 $2.95 $29,500 29,210
(Direct)
View
2017-08-17
Purchase
2017-08-21
4:49 pm
Xenon Pharmaceuticals Inc. XENE AZAB MOHAMMAD
Director
6,335 $2.899 $18,363 19,210
(Direct)
View
2017-08-18
Purchase
2017-08-21
4:48 pm
Xenon Pharmaceuticals Inc. XENE WINQUIST RAYMOND
Head, Translational Research
1,000 $2.995 $2,995 1,000
(Direct)
View
2017-08-15
Purchase
2017-08-17
5:33 pm
Xenon Pharmaceuticals Inc. XENE EMPFIELD JAMES R.
SVP, Drug Discovery
10,000 $2.482 $24,824 10,000
(Direct)
View
2017-08-14
Purchase
2017-08-16
6:55 pm
Xenon Pharmaceuticals Inc. XENE BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner
60,202 $2.612 $157,267 1,674,468
(Direct)
View
2017-08-14
Purchase
2017-08-15
4:54 pm
Xenon Pharmaceuticals Inc. XENE Svoronos Dawn
Director
50,000 $2.815 $140,770 50,000
(Direct)
View
2017-08-10
Purchase
2017-08-14
6:07 pm
Xenon Pharmaceuticals Inc. XENE PATOU GARY
Director
7,500 $2.778 $20,836 12,500
(Direct
Indirect)
View
2017-08-10
Purchase
2017-08-14
6:07 pm
Xenon Pharmaceuticals Inc. XENE MORTIMER IAN
CFO & COO
15,000 $2.882 $43,225 14,300
(Direct
Indirect)
View
2017-08-10
Purchase
2017-08-14
6:07 pm
Xenon Pharmaceuticals Inc. XENE SCHELLER RICHARD H
Director
7,000 $2.85 $19,950 7,000
(Direct)
View
2017-08-10
Purchase
2017-08-14
6:06 pm
Xenon Pharmaceuticals Inc. XENE PIMSTONE SIMON N.
President & CEO
Director
6,000 $2.9 $17,400 217,847
(Indirect
Direct)
View
2017-08-14
Purchase
2017-08-14
6:06 pm
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
15,000 $2.75 $41,247 161,187
(Indirect
Direct)
View
2017-08-11
Purchase
2017-08-14
6:05 pm
Xenon Pharmaceuticals Inc. XENE GANNON STEVEN
Director
15,000 $2.818 $42,267 15,000
(Direct)
View
2017-08-08
Purchase
2017-08-10
7:58 pm
Xenon Pharmaceuticals Inc. XENE PATOU GARY
Director
5,000 $3 $15,002 12,028
(Direct
Indirect)
View
2017-06-27
Purchase(A)
2017-06-30
12:00 pm
Xenon Pharmaceuticals Inc. XENE BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner
85,461 $3.036 $259,468 1,635,032
(Direct)
View
2017-06-27
Purchase
2017-06-29
6:21 pm
Xenon Pharmaceuticals Inc. XENE BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner
85,461 $4 $341,844 1,635,032
(Direct)
View
2017-06-21
Purchase
2017-06-23
7:16 pm
Xenon Pharmaceuticals Inc. XENE BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner
20,411 $4 $81,644 1,588,237
(Direct)
View
2017-06-15
Purchase
2017-06-19
7:33 pm
Xenon Pharmaceuticals Inc. XENE BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner
26,408 $3.844 $101,518 1,577,332
(Direct)
View
2017-06-06
Purchase
2017-06-08
6:58 pm
Xenon Pharmaceuticals Inc. XENE BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner
358,698 $3.809 $1,366,146 1,562,494
(Direct)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
Date
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-10-23
Option Award
2017-10-24
6:48 pm
N/A
2027-10-22
Xenon Pharmaceuticals Inc. XENE MORTIMER IAN
CFO & COO
25,000 $3.1 25,000
(Direct)
View
2017-10-23
Option Award
2017-10-24
6:46 pm
N/A
2027-10-22
Xenon Pharmaceuticals Inc. XENE ROBIN SHERRINGTON
SVP Bus. & Corp. Development
11,000 $3.1 11,000
(Direct)
View
2017-10-23
Option Award
2017-10-24
6:46 pm
N/A
2027-10-22
Xenon Pharmaceuticals Inc. XENE PIMSTONE SIMON N.
President & CEO
Director
11,000 $3.1 11,000
(Direct)
View
2017-10-23
Option Award
2017-10-24
6:45 pm
N/A
2027-10-22
Xenon Pharmaceuticals Inc. XENE GOLDBERG Y. PAUL
SVP, Clinical Development
11,000 $3.1 11,000
(Direct)
View
2017-10-23
Option Award
2017-10-24
6:44 pm
N/A
2027-10-22
Xenon Pharmaceuticals Inc. XENE EMPFIELD JAMES R.
SVP, Drug Discovery
20,000 $3.1 20,000
(Direct)
View
2017-10-23
Option Award
2017-10-24
6:43 pm
N/A
2027-10-22
Xenon Pharmaceuticals Inc. XENE COHEN CHARLES J.
VP, Biology
11,000 $3.1 11,000
(Direct)
View
2017-06-19
Exercise
2017-06-20
4:37 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE TARNOW MICHAEL M
Director
1,028 $3.51 56,195
(Direct)
View
2017-06-19
Gift
2017-06-20
4:37 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE TARNOW MICHAEL M
Director
1,028 $0 56,195
(Direct)
View
2017-06-19
Exercise
2017-06-20
4:37 pm
N/A
2017-06-30
Xenon Pharmaceuticals Inc. XENE TARNOW MICHAEL M
Director
1,028 $3.51 56,195
(Direct)
View
2017-06-01
Option Award
2017-06-02
5:06 pm
N/A
2027-05-31
Xenon Pharmaceuticals Inc. XENE SCHELLER RICHARD H
Director
3,500 $3.85 3,500
(Direct)
View
2017-06-01
Option Award
2017-06-02
5:04 pm
N/A
2027-05-31
Xenon Pharmaceuticals Inc. XENE AZAB MOHAMMAD
Director
3,500 $3.85 3,500
(Direct)
View
2017-06-01
Option Award
2017-06-02
5:02 pm
N/A
2027-05-31
Xenon Pharmaceuticals Inc. XENE GANNON STEVEN
Director
3,500 $3.85 3,500
(Direct)
View
2017-06-01
Option Award
2017-06-02
5:00 pm
N/A
2027-05-31
Xenon Pharmaceuticals Inc. XENE PATOU GARY
Director
3,500 $3.85 3,500
(Direct)
View
2017-06-01
Option Award
2017-06-02
4:58 pm
N/A
2027-05-31
Xenon Pharmaceuticals Inc. XENE TARNOW MICHAEL M
Director
3,500 $3.85 3,500
(Direct)
View
2017-06-01
Option Award
2017-06-02
4:58 pm
N/A
2027-05-31
Xenon Pharmaceuticals Inc. XENE TARNOW MICHAEL M
Director
1,250 $3.85 3,500
(Direct)
View
2017-06-01
Option Award
2017-06-02
4:56 pm
N/A
2027-05-31
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
3,500 $3.85 3,500
(Direct)
View
2017-06-01
Option Award
2017-06-02
4:53 pm
N/A
2027-05-31
Xenon Pharmaceuticals Inc. XENE HOLLER FRANK A
Director
3,500 $3.85 3,500
(Direct)
View
2017-06-01
Option Award
2017-06-02
4:51 pm
N/A
2027-05-31
Xenon Pharmaceuticals Inc. XENE Svoronos Dawn
Director
3,500 $3.85 3,500
(Direct)
View
2017-05-12
Exercise
2017-05-16
4:32 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE ROBIN SHERRINGTON
SVP Bus. & Corp. Development
2,057 $3.21 6,079
(Direct)
View
2017-05-12
Tax Withholding
2017-05-16
4:32 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE ROBIN SHERRINGTON
SVP Bus. & Corp. Development
1,345 $4.18 6,079
(Direct)
View
2017-05-12
Exercise
2017-05-16
4:32 pm
N/A
2017-05-18
Xenon Pharmaceuticals Inc. XENE ROBIN SHERRINGTON
SVP Bus. & Corp. Development
2,057 $3.21 6,079
(Direct)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
18,004 $3.7 146,187
(Direct)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
25,720 $3.76 146,187
(Direct)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
5,144 $3.67 146,187
(Direct)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
4,115 $3.77 146,187
(Indirect)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
4,629 $3.07 146,187
(Indirect)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
N/A
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
3,086 $3.56 146,187
(Indirect)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
2018-06-26
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
18,004 $3.7 146,187
(Direct)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
2020-12-31
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
25,720 $3.76 146,187
(Direct)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
2021-12-31
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
5,144 $3.67 146,187
(Direct)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
2017-12-31
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
4,115 $3.77 146,187
(Indirect)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
2018-12-31
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
4,629 $3.07 146,187
(Indirect)
View
2017-03-14
Exercise
2017-03-15
7:53 pm
N/A
2019-12-31
Xenon Pharmaceuticals Inc. XENE Hayden Michael R
Director
3,086 $3.56 146,187
(Indirect)
View
2017-03-13
Option Award
2017-03-14
4:28 pm
N/A
2027-03-12
Xenon Pharmaceuticals Inc. XENE EMPFIELD JAMES R.
SVP, Drug Discovery
27,500 $8.4 27,500
(Direct)
View
2017-03-13
Option Award
2017-03-14
4:28 pm
N/A
2027-03-12
Xenon Pharmaceuticals Inc. XENE COHEN CHARLES J.
VP, Biology
20,000 $8.4 20,000
(Direct)
View
2017-03-13
Option Award
2017-03-14
4:27 pm
N/A
2027-03-12
Xenon Pharmaceuticals Inc. XENE WINQUIST RAYMOND
Head, Translational Research
20,000 $8.4 20,000
(Direct)
View
2017-03-13
Option Award
2017-03-14
4:27 pm
N/A
2027-03-12
Xenon Pharmaceuticals Inc. XENE ROBIN SHERRINGTON
SVP Bus. & Corp. Development
27,500 $8.4 27,500
(Direct)
View
Goto page 0, 1, Next